Inoviq Share Price and Company Fundamentals



Price
$0.34
Change
-0.010 (-2.857%)
52 week range
0.32 - 0.69

Last traded: Today at 3:26 AM

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Key Metrics

PE ratio

-

PB ratio

2.27

Dividend yield

-

Beta

1.84

Market cap

$47.86M

Enterprise value

$32.93M

Company profile

Industry / Sector Diagnostics & Research / Healthcare
Website https://www.inoviq.com
Mailing address 23 Normanby Road Notting Hill VIC 3168 Australia
Phone / Fax 61 3 9548 7586 /

Dividends

More: Inoviq Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Inoviq paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IIQ dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Inoviq.

Name Title Age Total Pay
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., M.B.A., M.R.C.V.S. Chief Executive Officer
Mr. Mark Edwards BACC, C.A. CFO & Company Secretary
Ms. Rebecca Lim Chief Scientific Officer
Dr. Emma Ball B.Sc., M.B.A., Ph.D. Chief Commercial Officer

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-350.25%

Return on assets

-22.86%

Return on equity

-37.78%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Inoviq is 47.86M and its enterprise value is 32.93M. The enterprise value to revenue ratio of IIQ is 18.14. The enterprise value to EBITDA ratio of IIQ is -5.35.

The IIQ's stocks Beta value is 1.84 making it 84% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Inoviq (IIQ)

Inoviq (ASX:IIQ) Frequently Asked Questions

1. What is Inoviq's Stock Symbol?

Inoviq trades on ASX under the ticker symbol "IIQ".

2. What is Inoviq's stock price today?

One share of IIQ stock can currently be purchased for approximately $0.34.

3. How can I contact Inoviq?

Inoviq's mailing address is 23 Normanby Road Notting Hill VIC 3168 Australia. The company can be reached via phone at 61 3 9548 7586.

4. What is Inoviq's official website?

The official website of Inoviq is https://www.inoviq.com.